Corticosteroid injections are overused on racehorses but don't contribute to catastrophic breakdowns, a medication consultant said during a June 27 continuing education program for licensed Thoroughbred horsemen in Indiana.
Diagnosing and treating upper and lower respiratory issues and the use of corticosteroids in racehorses will be discussed as part of a continuing education seminar for trainers June 27 at Indiana Downs.
Dr. Scot Waterman, most recently executive director of the Racing Medication and Testing Consortium, has been hired as the first animal medication and welfare adviser for the Arizona Department of Racing.
As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.
- By Tom LaMarra
Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium for almost 10 years, is leaving the post at the end of April, according to multiple industry sources.
The West Virginia Senate Feb. 25 passed an overhaul of the state's horse racing regulations, which include mandatory pre-race veterinary exams for horses.
Grayson-Jockey Club Research Foundation's summit to be held at the Keeneland sale pavilion June 28-29; will be streamed live on Keeneland's website.
A Thoroughbred leadership group called Vision 20/20 has been formed by the Kentucky Thoroughbred Association/Kentucky Thoroughbred Owners and Breeders in order to strengthen the industry.
- By Tom LaMarra
The sensitivity of equine drug testing is a big plus for the racing industry, but it also has created confusion. How are the public and media supposed to understand when some industry participants can't make sense of it?
A seminar focused on drug testing and the prosecution of a medication case will be the focus of the Racing Officials Accreditation Programfs second annual Officiating Horse Racing Conference at the University of Arizona Race Track Industry Programfs Symposium on Racing and Gaming.
The Racing Medication and Testing Consortium is developing protocol designed to streamline and improve equine drug-testing in the United States. And it is taking a few pages from a 1991 study that didn't gain any traction in the racing industry when it was released.
The Thoroughbred Owners and Breeders Association announced March 26 that it has launched a new webcast entitled "Recent Advances and New Innovations in Equine Drug Testing."
The Thoroughbred Owners and Breeders Association, trainer Michael Matz, and owners Roy and Gretchen Jackson, have invited the public to attend a presentation by Dr. Lawrence R. Soma of the University of Pennsylvania School of Veterinary Medicine's New Bolton Center and Dr. Scot Waterman of the Racing Medication and Testing Consortium.
The Racing Medication and Testing Consortium sponsored an equine racing chemist workshop to foster uniformity in drug testing of the androgenic anabolic steroids from April 27-30 at the University of California at Davis.
After nearly five years in existence, the Racing Medication and Testing Consortium is refocusing on some of its core goals such as uniform rules, drug research, and standardizing drug-testing procedures in the United States.
Word is circulating in Kentucky that cobra venom, a substance used to kill pain, was found by investigators during a June 26 search of trainer Patrick Biancone's barn at Keeneland.
Implementation of a training stable that would produce samples for equine drug testing, and hiring of an equine medical director have the support of the Kentucky Equine Drug Research Council, but both are hold for at least a few months.
Positives for a methamphetamine-like drug in racehorses have several laboratories and investigators working to determine its origin.
A Nebraska veterinarian has been accused of injecting racehorses with vodka. It is believed to be the first prosecution for administering alcohol to racehorses in the United States.
Members of the Hambletonian Society said they've made personal and collective commitments to raise $100,000 for the continued funding of the Racing Medication and Testing Consortium. The decision was made at the July meeting of the society, which has been involved with the RMTC since last year.
J. Patrick Barrett, chairman of the Ad Hoc Committee on the Future of Horse Racing in New York, will discuss the role and work of the committee over the past year when he delivers the keynote address Aug. 20 at The Jockey Club Round Table Conference in Saratoga Springs, N.Y.
Out-of-competition testing of racehorses can be problematic, but some jurisdictions are making headway to combat use of performance-enhancing substances that aren't administered on race day.
Model rules for race day medications, along with withdraw times and threshold levels for therapeutic drugs were a lively topic both Thursday morning and afternoon at the Association of Racing Commissioners International convention.
The national Racing Medication and Testing Consortium, which has succeeded in getting most or all of its model rules package for raceday medication and drug testing approved in a majority of jurisdictions, is officially seeking financial commitments from industry stakeholders to support ongoing integrity efforts.
Based on field reports that racehorses are receiving vodka intravenously in an attempt to calm them down before races, the Racing Medication and Testing Consortium has authorized laboratories to develop a test for alcohol.
The Board of Directors of the Racing Medication and Testing Consortium (RMTC) commissioned Dr. Rick Sams of Ohio State to develop an action plan, timeline, and research priorities to establish guidelines for withdrawal times for therapeutic medications commonly used by racetrack veterinarians.
The Racing Medication and Testing Consortium has set a deadline for adoption of recommended uniform medication violations and testing protocol for "milkshakes," which are mixtures of bicarbonate of soda and a liquid force-fed to a racehorse before it competes.
Dan Fick, executive vice president and executive director of The Jockey Club, was elected chairman of the Racing Medication and Testing Consortium at its quarterly meeting Sept. 9. The consortium also approved a per-start fee for horse owners to help fund initiatives.
Three months after national regulators' associations approved model rules for a proposed national medication policy, the task of lobbying jurisdictions to adopt them continues.
The Racing Medication and Testing Consortium has approved policy language on race-day use of Salix and non-steroidal anti-inflammatory drugs, as well as environmental contaminants, and also formed a subcommittee to review race-day security practices.
The perception of wrongdoing in racing is strong enough that regulators and marketers must not dismiss it, officials said Dec. 11 during a panel discussion titled "The Changing Environment of Regulation" at the University of Arizona Symposium on Racing.
The Racing Medication and Testing Consortium continued its march toward a national model policy on medication and drug testing Dec. 10 when regulators responded favorably to the proposal. But wholesale changes in race-day medication rules around the country aren't expected to take place any time soon.
Though regulators on Dec. 10 will examine a proposal for a national medication and drug-testing policy, release of the document to the public hinges on how well it is received during the meeting.
The Racing Medication and Testing Consortium has made substantial progress on a model policy for the horse racing industry and also has allocated $275,000 for four research projects tied to its initiatives.
With a goal to raise $2 million to $3 million a year to support its initiatives, the Racing Medication and Testing Consortium is looking at a mechanism that would raise money from horsemen and racetracks based on the top four finishers in each race.
Participants in a July 10 medication workshop reached the consensus that "over-medication" may contribute to fewer starts by racehorses, but other factors -- racetrack surfaces, an emphasis on speed, too much pressure on 2-year-olds, and a thirst for quick profit -- probably are just as responsible.
The American Graded Stakes Committee will begin implementing a drug-testing plan for horses participating in its designated races beginning at Keeneland and Belmont Park this fall. It expects to have the testing protocol fully in place by the end of 2004.
The Racing Medication and Testing Consortium has elected officers, chosen an executive director, and put the finishing touches on few sections of its proposed model policy for medication and drug testing. Breeders' Cup president D.G. Van Clief Jr. was elected chairman.
The Racing Medication and Testing Consortium is scheduled to meet Feb. 4 in Atlanta, Ga., to hammer out details of its structure and further develop its policy statement.
The Racehorse Medication and Testing Consortium formed earlier this year has incorporated as a charitable organization and issued its goals and objectives, one of which has been broadened to include the auction and training aspects of the Thoroughbred business.
The Racing Medication and Testing Consortium is moving forward with a national policy statement and plans to incorporate.
Issues surrounding ownership, medication, equine genomics and the globalization of racing will be spotlighted when The Jockey Club's 50th annual Round Table Conference on Matters Pertaining to Racing convenes at the Sheraton Hotel and Conference Center in Saratoga Springs, N.Y., on Aug. 18.
In the second round of "super tests" performed under the guidance of the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force, there were no new positives for Class 1, 2, and 3 medications, according to a final report recently released. There were, however, 454 confirmations for therapeutic drugs.
The newly christened Racing Medication and Testing Consortium said May 1 it has formed three task forces to focus on developing an organizational and business plan, scientific research priorities, and a model medication policy.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.
Jim Gallagher, executive director of the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force, will leave the organization March 28 to take the position of vice president of pari-mutuel operations for the New York Racing Association.
The second round of "super-test" results from the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force should be released early in January, said Jim Gallagher, executive director of the task force.
The National Thoroughbred Racing Association's Racing Integrity and Drug Testing Task Force will attempt to break down barriers that separate breeds in an attempt to shore up drug-testing procedures in horse racing.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
Most Popular Stories
- Top Mare Nastique Dies at 29
- Panelists to Horse Racing: Spin Isn't In
- St Nicholas Abbey Progresses in Recovery
- Giving 'L' Legitimacy - Eric Mitchell
- Racing is Ripe for More Advanced Statistics
- BloodHorse.com New Navigation Tour
- NYRA Chief Discusses Aspects of Growth Plan
- Castellano Closing on Season Earnings Record
- Suffolk Casino Project to be Put to New Vote
- Slideshow: Royal Delta